[go: up one dir, main page]

FI962299L - Hirudiinista ja lipofiilisistä yhdisteistä muodostuneet hirudiini-konjugaatit - Google Patents

Hirudiinista ja lipofiilisistä yhdisteistä muodostuneet hirudiini-konjugaatit Download PDF

Info

Publication number
FI962299L
FI962299L FI962299A FI962299A FI962299L FI 962299 L FI962299 L FI 962299L FI 962299 A FI962299 A FI 962299A FI 962299 A FI962299 A FI 962299A FI 962299 L FI962299 L FI 962299L
Authority
FI
Finland
Prior art keywords
hirudin
lipophilic compounds
conjugates formed
lipophilic
compounds
Prior art date
Application number
FI962299A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI962299A7 (fi
FI962299A0 (fi
Inventor
Juergen Schweden
Peter Eckes
Wilfried Hornberger
Thomas Subkowski
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of FI962299L publication Critical patent/FI962299L/fi
Publication of FI962299A7 publication Critical patent/FI962299A7/fi
Publication of FI962299A0 publication Critical patent/FI962299A0/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/545Heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Fats And Perfumes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Ink Jet (AREA)
  • Extrusion Moulding Of Plastics Or The Like (AREA)
  • Silicon Polymers (AREA)
FI962299A 1993-12-02 1994-11-25 Hirudiinista ja lipofiilisistä yhdisteistä muodostuneet hirudiini-konjugaatit FI962299A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4341115 1993-12-02
PCT/EP1994/003901 WO1995015183A1 (de) 1993-12-02 1994-11-25 Hirudin-konjugate aus hirudin und lipophilen verbindungen

Publications (3)

Publication Number Publication Date
FI962299L true FI962299L (fi) 1996-05-31
FI962299A7 FI962299A7 (fi) 1996-05-31
FI962299A0 FI962299A0 (fi) 1996-05-31

Family

ID=6504029

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962299A FI962299A0 (fi) 1993-12-02 1994-11-25 Hirudiinista ja lipofiilisistä yhdisteistä muodostuneet hirudiini-konjugaatit

Country Status (25)

Country Link
US (1) US5919762A (pt)
EP (1) EP0730473B1 (pt)
JP (1) JPH09505810A (pt)
CN (1) CN1142776A (pt)
AT (1) ATE204763T1 (pt)
AU (1) AU679811B2 (pt)
BR (1) BR9408195A (pt)
CA (1) CA2176967A1 (pt)
CZ (1) CZ157096A3 (pt)
DE (2) DE4437502A1 (pt)
DK (1) DK0730473T3 (pt)
ES (1) ES2163487T3 (pt)
FI (1) FI962299A0 (pt)
GR (1) GR3036938T3 (pt)
HR (1) HRP940968A2 (pt)
HU (1) HUT74390A (pt)
IL (1) IL111811A0 (pt)
NO (1) NO962261L (pt)
NZ (1) NZ276410A (pt)
PL (1) PL314797A1 (pt)
PT (1) PT730473E (pt)
SG (1) SG49156A1 (pt)
SK (1) SK67596A3 (pt)
WO (1) WO1995015183A1 (pt)
ZA (1) ZA949562B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4437604A1 (de) * 1994-10-21 1996-04-25 Basf Ag Konjugate aus einem Poly- oder Oligopeptid und einer niedermolekularen lipophilen Verbindung
US5726168A (en) * 1995-10-12 1998-03-10 Eli Lilly And Company Lipophilic benzothiophenes
USD438964S1 (en) 1997-11-07 2001-03-13 Graphic Controls Corporation Cabinet and container for housing medical waste
DE19915862A1 (de) * 1999-04-08 2000-10-12 Max Planck Gesellschaft Verwendung von molekulargewichtserweitertem Hirudin als Antikoagulans bei der extrakorporalen Nierenersatztherapie
JP4394444B2 (ja) * 2001-10-24 2010-01-06 パワー ペーパー リミティド 活性物質の制御された皮膚内デリバリーのためのデバイス及び方法
US7438925B2 (en) * 2002-08-26 2008-10-21 Biovention Holdings Ltd. Drug eluting coatings for medical implants
BR102017005783A2 (pt) * 2017-03-21 2018-10-02 Fund Butantan processo de obtenção de esculptina e seus fragmentos, esculptina recombinante e seus usos
KR102366360B1 (ko) * 2021-06-29 2022-02-23 (주)네오팜 신규한 유사 세라마이드 화합물 및 이를 포함하는 피부 외용제 조성물

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3264782D1 (en) * 1981-10-16 1985-08-22 Sanol Arznei Schwarz Gmbh Medicinal formulation
DE3445532A1 (de) * 1984-12-13 1986-06-19 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Hirudin-pa, desulfatohirudine-pa, verfahren zur herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten
US4939174A (en) * 1988-02-26 1990-07-03 Shashoua Victor E Appetite suppression with dopamine-fatty acid conjugates
DE3819079A1 (de) * 1988-06-04 1989-12-07 Hoechst Ag Hirudin-derivate mit verzoegerter wirkung
ATE104857T1 (de) * 1989-03-07 1994-05-15 Genentech Inc Kovalente konjugate von lipiden und oligonukleotiden.
DE4014260A1 (de) * 1989-12-01 1991-06-06 Basf Ag Hirudinpolyalkylenglykolkonjugate
DE59010205D1 (de) * 1989-12-01 1996-04-18 Basf Ag Hirudin-Muteine und deren Polyalkylenglykolkonjugate
EP0506748B1 (en) * 1989-12-22 1995-12-13 Commonwealth Scientific And Industrial Research Organisation Amino acids, peptides or derivatives thereof coupled to fats
WO1991014696A1 (en) * 1990-03-29 1991-10-03 Gilead Sciences, Inc. Oligonucleotide-transport agent disulfide conjugates
US5256641A (en) * 1990-11-01 1993-10-26 State Of Oregon Covalent polar lipid-peptide conjugates for immunological targeting
WO1992019233A2 (en) * 1991-04-29 1992-11-12 Control Delivery Systems, Inc. Sustained release composition and methods of use thereof
EP0541737B1 (fr) * 1991-05-02 1997-04-09 BAUDET, Pierre Les n-phenyl-cinnamamides, protecteurs contre les effets nocifs de la lumiere ultra-violette
US5359030A (en) * 1993-05-10 1994-10-25 Protein Delivery, Inc. Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same

Also Published As

Publication number Publication date
GR3036938T3 (en) 2002-01-31
HUT74390A (en) 1996-12-30
EP0730473A1 (de) 1996-09-11
CA2176967A1 (en) 1995-06-08
JPH09505810A (ja) 1997-06-10
NZ276410A (en) 1997-03-24
NO962261D0 (no) 1996-05-31
SK67596A3 (en) 1996-12-04
PL314797A1 (en) 1996-09-30
DE4437502A1 (de) 1995-06-08
NO962261L (no) 1996-05-31
DE59409847D1 (de) 2001-10-04
AU679811B2 (en) 1997-07-10
WO1995015183A1 (de) 1995-06-08
HRP940968A2 (en) 1997-08-31
US5919762A (en) 1999-07-06
HU9601471D0 (en) 1996-07-29
ATE204763T1 (de) 2001-09-15
DK0730473T3 (da) 2001-10-08
BR9408195A (pt) 1997-08-26
CZ157096A3 (en) 1996-09-11
CN1142776A (zh) 1997-02-12
FI962299A7 (fi) 1996-05-31
SG49156A1 (en) 1998-05-18
AU1067095A (en) 1995-06-19
ZA949562B (en) 1996-06-03
EP0730473B1 (de) 2001-08-29
FI962299A0 (fi) 1996-05-31
ES2163487T3 (es) 2002-02-01
IL111811A0 (en) 1995-01-24
PT730473E (pt) 2002-02-28

Similar Documents

Publication Publication Date Title
FI944310L (fi) Heteroaryyliamino- ja heteroaryylisuolfonamidosubstituoituja 3-bentsyyliaminometyylipiperidiinejä ja vastaavia yhdisteitä
FI961599A7 (fi) 1N-alkyyli-N-aryylipyrimidiiniamiineja ja niiden johdannaisia
FI951210A7 (fi) Varjoaineisiin liittyviä parannuksia
DK0719278T3 (da) Androstenonderivat
FI953351L (fi) Seokset ja niiden käyttö
FI954325L (fi) Varjoaineisiin liittyviä parannuksia
FI942881A7 (fi) 2-piperatsinoniyhdisteet ja niiden käyttö
FI944624A0 (fi) 4-aryyliaminobentsopyraani- ja niiden kaltaisia yhdisteitä
DE59207053D1 (de) Kettenumlenkung
FI935728A7 (fi) Substituoituja 4-fenyylipyridoneja ja 4-fenyyli-2-alkoksipyridiinejä
FI954326A7 (fi) Varjoaineisiin liittyviä parannuksia
DE69405479D1 (de) Resistmaterialien
KR930009166U (ko) 소각로
DE59403737D1 (de) Drehkreuz
FI962299A7 (fi) Hirudiinista ja lipofiilisistä yhdisteistä muodostuneet hirudiini-konj ugaatit
FI955605L (fi) Aryloivia lääkkeitä
NO944313D0 (no) Detektor
KR950702293A (ko) 차동장치
KR940025159U (ko) 소각로
BR9200689A (pt) Composicao profilatica
KR950006830U (ko) 소각로
KR950001738U (ko) 소각로
BR7302492U (pt) Incinerador eletro-automático
KR950019819U (ko) 소각기
KR950009407U (ko) 소각로

Legal Events

Date Code Title Description
FD Application lapsed